AU5507098A - Enhancement of dna immunization through the use of cytokines - Google Patents

Enhancement of dna immunization through the use of cytokines

Info

Publication number
AU5507098A
AU5507098A AU55070/98A AU5507098A AU5507098A AU 5507098 A AU5507098 A AU 5507098A AU 55070/98 A AU55070/98 A AU 55070/98A AU 5507098 A AU5507098 A AU 5507098A AU 5507098 A AU5507098 A AU 5507098A
Authority
AU
Australia
Prior art keywords
cytokines
enhancement
dna immunization
immunization
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55070/98A
Inventor
Kari R. Irvine
Nicholas P Restifo
Steven A Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU5507098A publication Critical patent/AU5507098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
AU55070/98A 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines Abandoned AU5507098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57507295A 1995-12-19 1995-12-19
US08575072 1995-12-19
PCT/US1996/020571 WO1998008947A1 (en) 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines

Publications (1)

Publication Number Publication Date
AU5507098A true AU5507098A (en) 1998-03-19

Family

ID=24298818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55070/98A Abandoned AU5507098A (en) 1995-12-19 1996-12-18 Enhancement of dna immunization through the use of cytokines

Country Status (2)

Country Link
AU (1) AU5507098A (en)
WO (1) WO1998008947A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2309766C (en) 1997-11-20 2008-09-30 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
WO1999030734A1 (en) * 1997-12-18 1999-06-24 G.D. Searle & Co. Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
AU743226B2 (en) * 1998-01-16 2002-01-24 Johns Hopkins University, The Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
KR100622716B1 (en) * 1998-02-12 2006-09-13 와이어쓰 홀딩스 코포레이션 Vaccines comprising interleukin-12 and herpes simplex viral antigen
CA2320223A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Pneumococcal and meningococcal vaccines formulated with interleukin-12
AU2011203139B2 (en) * 1998-02-27 2014-06-19 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same
US6528312B1 (en) 1998-05-06 2003-03-04 Transgene S.A. Use of G-actin for improving transfection of a polynucleotide into a cell
US6734172B2 (en) 1998-11-18 2004-05-11 Pacific Northwest Research Institute Surface receptor antigen vaccines
WO2000041679A1 (en) * 1999-01-13 2000-07-20 Johns Hopkins University School Of Medicine Genetic immunization with co-delivery of nucleic acid and cytokines
GB9923309D0 (en) * 1999-10-01 1999-12-08 Glaxo Group Ltd Assay
AU2596901A (en) * 1999-12-21 2001-07-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002249852A1 (en) 2000-11-09 2002-08-12 Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha
DE602004031341D1 (en) 2003-07-21 2011-03-24 Transgene Sa MULTIFUNCTIONAL CYTOKINE
CA2531773A1 (en) * 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
KR20230104175A (en) * 2020-11-05 2023-07-07 네오이뮨텍, 인코퍼레이티드 Methods of Treating Tumors Using Combinations of IL-7 Protein and Nucleotide Vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169635C (en) * 1993-08-26 2002-11-12 Dennis A. Carson Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
US5804566A (en) * 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
WO1995029193A2 (en) * 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
EP0789774A2 (en) * 1994-10-03 1997-08-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system

Also Published As

Publication number Publication date
WO1998008947A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU3150295A (en) Dna vaccines against rotavirus infections
AU1209897A (en) Novel dna polymerase
AU5324196A (en) Gene transfer into the kidney
AU5040896A (en) Benzonitriles and benzofluorides
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
AU7640296A (en) Goggles
AU4329396A (en) Use of 3,4-diphenylchromans
AU7640196A (en) Goggles
AU1050097A (en) Sequestrin
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU4902596A (en) Multi-function fluid treatment system and method for using the same
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2698795A (en) Human chemokine beta-12
AU4304193A (en) Flow transducer
AU7457596A (en) The aiolos gene
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
AU7694996A (en) Well fluid
AU7097696A (en) Novel human cc chemokine
ZA965709B (en) Benzylhydroxylamines and intermediates for their preparation.
AU2634095A (en) The use of an anti-helicobacter substance
AU1370397A (en) Process for the purification of recombinant human interleukin-8
AU5932296A (en) Dna encoding cellular homologue of the sv40 large t antigen
AU1205497A (en) Vaccine component
AU6623096A (en) Methods of predicting the outcome of infection
IL112916A0 (en) Modular-staircases which enable maximum use of the inner-space